Royal Bank of Canada Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $330.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price objective lifted by Royal Bank of Canada from $310.00 to ...
Royal Bank of Canada Cuts Verastem (NASDAQ:VSTM) Price Target to $14.00
Verastem (NASDAQ:VSTM – Free Report) had its price objective cut by Royal Bank of Canada from $16.00 to $14.00 in a report released on Friday morning,Benzinga reports. They currently have an ...
RBC upgrades Capita to “outperform,” citing favorable risk-reward balance
Despite the upgrade, risks remain. RBC cautioned that Capita must successfully convert its pipeline into revenue, maintain ...
UBS hires RBC Capital biotech bankers in U.S. health-care push
UBS Group AG has hired three investment bankers specializing in biotechnology from RBC Capital Markets as the bank expands ...
RBC Capital upgrades Capita to ‘outperform’
RBC Capital Markets upgraded Capita on Monday to ‘outperform’ form ‘sector perform’ and lifted the price target to 2,000p ...
Investing Snacks11h
Wells Fargo: Selling Shares, Cashing Dividends
Koss Olinger Consulting trimmed its Wells Fargo stake by 9.8%, selling 3,849 shares and bringing its total down to 35,536.